We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current NIRVF market cap is 0. The company's latest EPS is CAD and P/E is N/A.
| Year End 30 April 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -10k | -52k | -15k | -557k | -986k |
| Net Income | 13k | -314k | -254k | -5.65M | -1.49M |
| Year End 30 April 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
| Total Assets | 4k | 2k | 532k | 486k | 68k |
| Total Liabilities | 744k | 531k | 548k | 648k | 1.01M |
| Total Equity | -740k | -529k | -16k | -162k | -940k |
| Year End 30 April 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
| Operating | -42k | -20k | -155k | -490k | -333k |
| Investing | N/A | N/A | N/A | -101k | N/A |
| Financing | 4k | 22k | 629k | 2k | 310k |
| Market Cap | 0 |
| Price to Earnings Ratio | N/A |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 0 |
| Price to Book Ratio | 0 |
| Dividend Yield | - |
| Shares Outstanding | 34.03M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | - |
| 52 Week High | - |
| 52 Week Low | - |
| Spread (Intraday) | 0 (0%) |
| Company Name | Nirvana Life Sciences Inc (GM) |
| Address |
suite 2100, 650 west georgia street vancouver, british columbia V6B 4N8 |
| Website | https://www.nirvanalifescience.com |
| Industry | miscellaneous metal ores,nec (1099) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
